Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150432
Full metadata record
DC FieldValueLanguage
dc.creatorGonzález, RD
dc.creatorGomes, I
dc.creatorGomes, C
dc.creatorRocha, R
dc.creatorDurães, L
dc.creatorSousa, P
dc.creatorFigueruelo, M
dc.creatorRodríguez, M
dc.creatorPita, C
dc.creatorHornero, R
dc.creatorGómez, C
dc.creatorLopes, AM
dc.creatorPinto, N
dc.creatorMartins, S
dc.date.accessioned2023-06-27T13:24:24Z-
dc.date.available2023-06-27T13:24:24Z-
dc.date.issued2021
dc.identifier.issn2073-4425
dc.identifier.urihttps://hdl.handle.net/10216/150432-
dc.description.abstractThe primary genetic risk factor for late onset Alzheimer’s disease (LOAD) is the APOE4 allele of Apolipoprotein E (APOE) gene. The three most common variants of APOE are determined by single nucleotide polymorphisms (SNPs) rs429358 and rs7412. Our aim was to estimate allele and genotype frequencies of APOE variants in an Iberian cohort, thus helping to understand differences in APOE-related LOAD risk observed across populations. We analyzed saliva or buccal swab samples from 229 LOAD patients and 89 healthy elderly controls (=68 years old) from Northern Portugal and Castile and León region, Spain. The genotyping was performed by Sanger sequencing, optimized to overcome GC content drawbacks. Results obtained in our Iberian LOAD and control cohorts are in line with previous large meta-analyses on APOE frequencies in Caucasian populations; however, we found differences in allele frequencies between our Portuguese and Spanish subgroups of AD patients. Moreover, when comparing studies from Iberian and other Caucasian cohorts, differences in APOE2 and APOE4 frequencies and subsequent different APOE-related LOAD risks must be clarified. These results show the importance of studying genetic variation at the APOE gene in different populations (including analyses at a regional level) to increase our knowledge about its clinical significance.
dc.description.sponsorshipThis work was supported by ‘European Commission’ and ‘European Regional Development Fund’ (FEDER) under the project “Análisis y correlación entre el genoma completo y la actividad cerebral para la ayuda en el diagnóstico de la enfermedad de Alzheimer” (Project 0378_AD_EEGWA_2_P), (Cooperation Programme INTERREG V-A Spain-Portugal POCTEP 2014– 2020) and the COMPETE 2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020. Portuguese funds are supporting this work through FCT-Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Inovação in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274). IG, AML, SM, and NP are funded by FCT: CEECIND/02609/2017, IF/01262/2014, CEECIND/00684/2017, and through the Decreto-Lei n◦ 57/2016 de 29 de Agosto, respectively. Spanish funds are supporting this work through ‘Ministerio de Ciencia e Innovación–Agencia Estatal de Investigación’ and FEDER under project PGC2018-098214-A-I00 and by “CIBER en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)” through “Instituto de Salud Carlos III” co-funded with FEDER funds.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofGenes, vol.12(1):4
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleApoe variants in an iberian alzheimer cohort detected through an optimized sanger sequencing protocol
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/genes12010004
dc.relation.publisherversionhttps://www.mdpi.com/2073-4425/12/1/4
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-genes12010004.pdf1.56 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons